Clinical Trial Detail

NCT ID NCT02795156
Title Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors SCRI Development Innovations, LLC
Indications

larynx cancer

non-small cell lung carcinoma

biliary tract cancer

pancreatic cancer

nasal cavity cancer

paranasal sinus cancer

liver cancer

gastroesophageal junction adenocarcinoma

transitional cell carcinoma

esophageal cancer

oropharynx cancer

nasopharynx carcinoma

oral cavity cancer

Therapies

Afatinib

Regorafenib

Age Groups: adult

Additional content available in CKB BOOST